SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000918066-04-000011
Filing Date
2004-02-12
Accepted
2004-02-12 15:44:20
Documents
1
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001206350d20040212f5f.html 5  
1 PRIMARY DOCUMENT c0001206350d20040212f5f.xml 5 35376
  Complete submission text file 0000918066-04-000011.txt   37194
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST. BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET C/O GUILFORD PHARMACEUTICALS INC BALTIMORE MD 21224 4106316300
JORDAN ANDREW R (Reporting) CIK: 0001206350 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-23736 | Film No.: 04591465